merakiplace
Korea's leading telemedicine platform
Seoul, South Korea · Founded 2021
- Headquarters
- Seoul
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2C
- Website
- my-doctor.io
- Last Round
- Series AJun 2026
- Rounds
- 2
About
Merakiplace is a South Korean telemedicine platform operator behind My Doctor (나만의닥터), Korea's leading non-face-to-face medical consultation app. Founded in December 2021 by two McKinsey alumni, the company built a platform that modernizes and unifies South Korea's fragmented telemedicine market, connecting patients with doctors via mobile for remote consultations, prescriptions, and health management. In April 2022, it ranked first in overall startup growth rate in Korea. The platform operates under the brand 'My Doctor' (my-doctor.io) and has been recognized as a seed-stage company driving digital health innovation in South Korea.
Summary
merakiplace is a Healthcare company based in Seoul, South Korea, founded in 2021. Its most recent funding was a Series A round in Jun 2026. Investors include KB Investment.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...